Department of Oncology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211899, China.
Department of Oncology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211899, China.
Cytokine. 2022 Nov;159:156021. doi: 10.1016/j.cyto.2022.156021. Epub 2022 Aug 31.
Macrophages are highly enriched in renal cell carcinoma, and the inflammatory cytokines secreted by macrophages are remarkably associated with the survival rate of renal cell carcinoma. However, the relationship between gasdermin D (GSDMD) expression driven by macrophage and the invasion of renal cell carcinoma is not clear.
The Caki-2 and 786-O cells were co-cultured with monocytes cells (THP-1) derived macrophages, then the bio function changes of Caki-2 and 786-O cells and epithelial-mesenchymal transition of cancer cells were detected. Also, the role of IL-1β in Caki-2 and 786-O cells and macrophage interaction were investigated. Then, the animal model was used to confirm the role of communication of GSDMD with renal cell carcinoma in the tumor microenvironment.
CD68 and GSDMD were overexpressed in human renal cell carcinoma. GSDMD contributed to the secretion of IL‑1β in macrophages and was associated with the proliferation rate of renal cell carcinoma cells. Furthermore, silencing GSDMD elicited renal cell carcinoma cells motility through epithelial-mesenchymal transition change. The in vivo study confirmed that GSDMD promoted tumor progression and GSDMD knockout impaired renal cell carcinoma growth and metastases. Finally, the interactions between macrophages and renal cell carcinoma cells promoted renal cell carcinoma proliferation and metastasis, possibly mediated by IL-1β.
To our knowledge, this study showed that the GSDMD expressed by macrophages contributed to renal cell carcinoma cell growth, metastases, and epithelial-mesenchymal transition through regulating GSDMD/IL-1β axis and may be a novel therapeutic target and a potential biomarker for treating and diagnosing renal cell carcinoma.
巨噬细胞在肾细胞癌中高度富集,巨噬细胞分泌的炎症细胞因子与肾细胞癌的存活率显著相关。然而,巨噬细胞驱动的gasdermin D(GSDMD)表达与肾细胞癌侵袭之间的关系尚不清楚。
将 Caki-2 和 786-O 细胞与单核细胞衍生的巨噬细胞(THP-1)共培养,然后检测 Caki-2 和 786-O 细胞的生物功能变化和癌细胞的上皮-间充质转化。还研究了 IL-1β 在 Caki-2 和 786-O 细胞与巨噬细胞相互作用中的作用。然后,使用动物模型来确认 GSDMD 与肾细胞癌在肿瘤微环境中的通讯在肿瘤进展中的作用。
CD68 和 GSDMD 在人肾细胞癌中过表达。GSDMD 促进巨噬细胞中 IL-1β 的分泌,并与肾细胞癌细胞的增殖率相关。此外,沉默 GSDMD 通过上皮-间充质转化变化引发肾细胞癌细胞的迁移。体内研究证实 GSDMD 促进肿瘤进展,GSDMD 敲除可损害肾细胞癌的生长和转移。最后,巨噬细胞与肾细胞癌细胞之间的相互作用促进了肾细胞癌的增殖和转移,可能是通过 IL-1β 介导的。
据我们所知,本研究表明,巨噬细胞表达的 GSDMD 通过调节 GSDMD/IL-1β 轴促进肾细胞癌细胞的生长、转移和上皮-间充质转化,可能是治疗和诊断肾细胞癌的新的治疗靶点和潜在的生物标志物。